Azithromycin Lyme Disease

Azithromycin lyme disease






Azithromycin Increases Risk of Cardiovascular Death – A study published in the New England Journal of Medicine (May 2012) showed that only a short 5-day course of azithromycin therapy was associated with significant increases in the risk of both cardiovascular death and death from any cause.

Azithromycin is a commonly prescribed antibiotic for the symptoms of lyme disease. The treatment for lyme disease that most doctors prescribe is often a course of several antibiotics which are taken from various lengths of time –anywhere from 2 weeks up to 2 years in some cases.

Because the ventricular arrhythmias reported in conjunction with azithromycin use are often rapidly fatal, the researchers conducted a retrospective cohort study of mortality among patients who used this antibiotic.

The study cohort included persons with 347,795 prescriptions for azithromycin, 1,391,180 matched control periods with no study antibiotic treatment, 1,348,672 prescriptions for amoxicillin, 264,626 prescriptions for ciprofloxacin, and 193,906 prescriptions for levofloxacin.

When a 5-day course of azithromycin therapy was compared with a matched period of no antibiotic treatment, azithromycin was associated with an increased risk of both cardiovascular death and death from any cause during that 5-day interval.

This is a commonly used antibiotic for treating Lyme Disease by many Doctors, and now its clear it can be fatal.

It is also interesting to note that these deaths occurred only after a 5 day course of azithromycin. Can you imagine what the total number of deaths could be if this is taken for months or years as is often the case when it is prescribed for lyme disease patients?

The dangers of antibiotics are numerous, and this study has shown that azithromycin in particular can be deadly: azithromycin lyme disease. 

This entry was posted in Antibiotics, Blog. Bookmark the permalink.

Comments are closed.